<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Massive <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo> (PE) is characterized by systemic <z:hpo ids='HP_0002615'>hypotension</z:hpo> (defined as a systolic arterial pressure &lt; 90 mm Hg or a drop in systolic arterial pressure of at least 40 mm Hg for at least 15 min which is not caused by new <z:hpo ids='HP_0003674'>onset</z:hpo> <z:hpo ids='HP_0011675'>arrhythmias</z:hpo>) or shock (manifested by evidence of tissue hypoperfusion and <z:mp ids='MP_0005039'>hypoxia</z:mp>, including an altered level of consciousness, <z:hpo ids='HP_0100520'>oliguria</z:hpo>, or cool, clammy extremities) </plain></SENT>
<SENT sid="1" pm="."><plain>Massive <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo> has a high mortality rate despite advances in diagnosis and therapy </plain></SENT>
<SENT sid="2" pm="."><plain>A subgroup of patients with nonmassive PE who are hemodynamically stable but with right ventricular (RV) dysfunction or hypokinesis confirmed by echocardiography is classified as submassive PE </plain></SENT>
<SENT sid="3" pm="."><plain>Their prognosis is different from that of others with non-massive PE and <z:mpath ids='MPATH_458'>normal</z:mpath> RV function </plain></SENT>
<SENT sid="4" pm="."><plain>This article attempts to review the evidence-based risk stratification, diagnosis, initial stabilization, and management of massive and nonmassive <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo> </plain></SENT>
</text></document>